FDA revokes authorization for last remaining monoclonal antibody treatment

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Dec 8, 2022

One of our tools to fight COVID is now no longer an option as the FDA has officially revoked its authorization for the last remaining monoclonal antibody treatment.

Category: Health

Be the first to comment

Sign in

FDA revokes authorization for last remaining monoclonal antibody treatment